Taubman Institute welcomes new gift officer

The Taubman Institute has a new ally in its quest to support the lifesaving work of U-M’s most promising clinician-scientists.

Maria Muller has been assigned by the university’s office of medical development to serve as the Taubman Institute’s lead development officer.  She’ll be working with benefactors and prospective supporters to create giving opportunities that fulfill the aims of donors while underwriting important institute efforts such as the Emerging Scholars Program. 

Muller brings a robust background in higher education fundraising.  A native of Ohio, she began her development career at Harvard University, shepherding major gifts for Harvard’s business and public health schools, the Kennedy School of Government and the fundraising activities of the university president’s office among others. 

Returning to her Midwestern roots, Muller served as a major gifts officer for the U-M College of Engineering, working with alumni and individual supporters, facilitating corporate support of scholarships, internships and other initiatives.  But the special rewards and challenges of engaging support for medical research really appeal to her, she says.

“People want to be actively engaged, and at the Taubman Institute we have very special opportunities for that,” Muller said.  “There is a way to help our donors be part of the dynamic conversation about healthcare, and to experience the transformative power of individual philanthropy -- right here where we are aggressively working to save people.  For a development officer, that’s rarefied air.”

“We are delighted, and very fortunate, to have Maria as our colleague and champion,” said Taubman Institute Director Eva L. Feldman, M.D., Ph.D.  “The scholars and I, along with Mr. Taubman, are very impressed by her acumen, energy and enthusiasm.  I know our generous supporters will greatly enjoy working with her.”

You can reach Maria Muller at (734) 763-6249 or This email address is being protected from spambots. You need JavaScript enabled to view it.


Help Us Make A Difference. Make A Donation That Could Save Lives.

Make A Gift


Follow Us / Friend Us

Discovery-driven research that matters


Taubman Scholar Dr. Charles Burant tests promising diabetes drug

TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study.

Read more

Taubman Institute leaders make the case for more doctor-scientist funding


The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts.

The article explores the problematic gap between bench research and clinical application of new treatments or cures. 

Read more

Help Us Make A Difference. Make A Gift.

Leaders from the realms of business, academia and the community help to refine the Taubman Institute's vision, to monitor progress and to provide support, advice and counsel.

Meet the Leadership Advisory Board

Meet the Scientific Advisory Board

About Taubman Institute Video

In this video feature, Taubman Scholars explain why funding for high-risk research is so important to their work and to the discovery of promising cures and treatments.  


Stem cell surgery targets ALS Video

Patients glean hope from trial’s progress but wish it were faster


video-emerging-scholars-programDonors pitch in to keep brilliant science minds at U-M Video

Emerging Scholars program connects promising M.D.-researchers with philanthropists